Filing Details

Accession Number:
0001562180-25-003726
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-09 19:00:36
Reporting Period:
2025-05-07
Filing Date:
2025-05-09
Accepted Time:
2025-05-09 19:00:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1459839 Si-Bone Inc. SIBN Surgical & Medical Instruments & Apparatus (3841) 262216351
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1853089 Anshul Maheshwari C/O Si-Bone, Inc
471 El Camino Real, Suite 101
Santa Clara CA 95050
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-05-07 4,937 $17.00 265,356 No 4 S Direct
Common Stock Disposition 2025-05-08 28,350 $18.17 237,006 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
  2. The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.00 to $17.03, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
  3. The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.00 to $18.37, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
  4. Includes 180,329 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.